Ropes & Gray advised ImmunoGen on the deal. ImmunoGen, a leader in the field of antibody-drug conjugates for the treatment of cancer, announced a global, multi-year...
ImmunoGen’s Global Multi-Target License Agreement with Eli Lilly
Arbor Biotechnologies’ $215 Million Series B Financing
Ropes & Gray advised Arbor Biotechnologies on the deal. Arbor Biotechnologies announced an oversubscribed and up-sized $215 million Series B financing. Arbor plans to use the...
Blackstone Life Sciences’ $250 Million Investment in Cellex Group
Noerr and Morgan, Lewis & Bockius advised Cellex Cell Professionals GmbH on the deal. Ropes & Gray advised Blackstone Life Sciences. The Dresden-based Cellex Group announced...
OutSystems’ $150 Million Capital Raise
Ropes & Gray represented Abdiel Capital Advisors as the co-lead investor in the transaction. OutSystems, the leading modern application platform, announced a $150 million capital raise....